Table 3

Post-coronary heart disease event exposure of cardiovascular medications by CKD status.*

Medication Class

CKD (N = 159)

Medication Possession Ratio (SD)

Non-CKD (N = 1088)

Medication Possession Ratio (SD)

P Value


Statin

0.82 (0.25)

N = 155

0.79 (0.27)

N = 1034

0.3


β-blockers

0.78 (0.30)

N = 146

0.74 (0.3)

N = 1026

0.2


Calcium channel blockers

0.47 (0.38)

N = 80

0.39 (0.37)

N = 350

0.06


Angiotensin converting enzyme inhibitors

0.50 (0.39)

N = 137

0.58 (0.38)

N = 874

0.03


Angiotensin receptor blockers

0.50 (0.35)

N = 36

0.52 (0.34)

N = 203

0.8


*CKD indicates chronic kidney disease

Bansal et al. BMC Nephrology 2011 12:44   doi:10.1186/1471-2369-12-44

Open Data